Navigation Links
Echo Therapeutics to Present at the Oppenheimer Healthcare Conference
Date:12/7/2011

PHILADELPHIA, Dec. 7, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., Chairman & CEO of Echo Therapeutics, will present at the Oppenheimer 22nd Annual Healthcare Conference.

Dr. Mooney will make a presentation to prospective corporate partners and investors on Wednesday, December 14th at 3:20 PM ET.  The Company's presentation will be delivered at the Waldorf Astoria Hotel in New York City.  

About Echo Therapeutics

Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.

For More Information:
Christine Olimpio
Director, Investor Relations & Corporate Communications
(215) 717-4104


'/>"/>
SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Pepscan Therapeutics Presents Protein Mimicry Platform for the Discovery of anti-GPCR Antibodies at International Antibody Conference
2. ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
3. Echo Therapeutics Announces Pricing of $5.4 Million Registered Direct Equity Financing
4. FDA Sets April 24, 2012 as PDUFA Goal Date for Cell Therapeutics Resubmitted Pixantrone New Drug Application
5. GiiResearch.com: Polycystic Ovarian Syndrome (PCOS) Therapeutics - Market to Witness Static Growth Until 2018
6. Novelos Therapeutics Prices $5.9 Million Public Offering
7. Unigenes Proprietary Peptelligence™ Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist
8. Antiviral Therapeutics - Technologies, Markets and Companies
9. Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
10. Cara Therapeutics Initiates Phase I Study with Oral Formulation of Novel Peripherally-Acting Kappa Opioid Agonist
11. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Pharmavite LLC announced that Timothy "Tim" Toll has ... Toll recently served as Pharmavite,s executive vice president of ... label and sales administration in the United ... will expand his responsibilities to include international sales, global ... to chief customer officer is part of a plan ...
(Date:7/23/2014)... 23, 2014 /PRNewswire-iReach/ -- The Centers for Medicare & ... Innovation Network-Quality Improvement Organization (QIN-QIO) contract to a partnership ... Effective August 1, WVMI will launch Quality Insights ... , Pennsylvania , Delaware ... Louisiana.  The Network will engage providers and the community ...
(Date:7/23/2014)... /PRNewswire-iReach/ -- Use of Risk Evaluation and Mitigation Strategies ... market entry results in $5.4 billion in lost savings ... by economic consulting firm Matrix Global Advisors ... Required by the Food and Drug Administration ... are intended to improve drug safety by ensuring that ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry 2
... Texas, July 14, 2011 Convergen LifeSciences ... 7,977,468 has been awarded by the U.S. Patent and ... Board of Regents and The Secretary, U.S. Department of ... of 23 patents, pending or issued worldwide, licensed exclusively to ...
... REDWOOD CITY, Calif., July 14, 2011 Codexis, Inc. (Nasdaq: ... in the 13th Annual Pacific Crest Global Technology Leadership Forum, ... Robert Lawson, Senior Vice President and Chief Financial Officer, will ... Biofuels and Renewable Chemicals," scheduled for August 8 at 12:30 ...
Cached Medicine Technology:Convergen LifeSciences Announces Patent Award 2
(Date:7/23/2014)... Greenville, SC (PRWEB) July 23, 2014 AidJoy ... celebration of philanthropy at Zen on September 5, ... business community and AidJoy supporters are expected to attend this ... of our triumphs of the past six years," says Jess ... time to pause to reflect on this moment in AidJoy’s ...
(Date:7/23/2014)... "I wanted a better way to keep track of all ... pressure and pulse rate," said an inventor from Long Beach, ... a bunch of different devices, so I invented one that ... to make it easier to monitor health conditions. The invention ... enables the user to have more control over his or ...
(Date:7/23/2014)... athletes who suffered repeated blows to the head during ... Those clumps suggest the athletes had a disease called ... tests that might be able to detect CTE in ... Chemical & Engineering News (C&EN) , the weekly news ... article, Lauren Wolf, a senior editor at C&EN, explains ...
(Date:7/23/2014)... The Centers for Disease Control and Prevention applauded ... 2010 to 2012. Formerly known as “the nation’s medicine ... to some of the strongest opiates, such as Oxycontin, which ... launched an initiative to crack down on these rampant pill ... that existed in the state just a few years ago. ...
(Date:7/23/2014)... Fla. (PRWEB) July 23, 2014 ... results from leading academic institutions uncovering the importance ... opinions surrounding the need for breast self-exams is ... there is proof today for keeping this healthy ... cases mislead about the significance of breast self-exams ...
Breaking Medicine News(10 mins):Health News:AidJoy’s Inaugural Gala to be Held September 5, 2014 2Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 2Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 3Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 4Health News:Historical and Current Research Points to Importance of Breast Self-Exams 2
... for New York Blood Center (NYBC), NEW YORK, ... a blood drive on Monday, June 2 at 1011 ... School Gymnasium. Hours are from,9:30am-3:00pm, The Archdiocese of ... York,Blood Center; His Eminence Edward Cardinal Egan serves as ...
... WASHINGTON, May 30 The Department of,Veterans Affairs (VA) ... identified as being ill or injured from Operation,Enduring Freedom ... over 500,000 OEF-OIF veterans who have been,discharged from active ... "We promised to reach out to every OEF ...
... whole milk is just as effective, costs less and is ... is also commonly used as an oral contrast agent in conjunction ... , The study included 215 patients undergoing abdominal and pelvic CT, ... patients were given an IV contrast media; 115 were also given ...
... Results from a pivotal Phase III clinical ... once-daily, investigational anticoagulant medication, was superior in preventing ... knee replacement (TKR) surgery. The head-to-head study compared ... the current standard of care. , Data from ...
... May 30 Insulet Corporation,(Nasdaq: PODD ), ... its,OmniPod(R) Insulin Management System, today announced the company ... Obesity Conference.,Management is scheduled to present an overview ... June 6, 2008 at The Hotel Nikko in ...
... New Video ,Milestones in Oncology, Presentations at ... Society for Translational Oncology,(STO) is pleased to announce ... valuable video presentations for practicing,oncologists., (Logo: ... on the occasion of the 2008 Annual Meeting ...
Cached Medicine News:Health News:New York's Catholic Archdiocese Hosting June 2 Blood Drive 2Health News:VA Begins Next Phase of Combat Vet Outreach 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 3Health News:Society for Translational Oncology Launches Updated Website 2
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
The S7 Lightweight offers the comfort and reliability of the award-winning S7 series in a convenient, affordable device....
Medicine Products: